WO1998018795A1 - Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte - Google Patents
Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte Download PDFInfo
- Publication number
- WO1998018795A1 WO1998018795A1 PCT/EP1997/005743 EP9705743W WO9818795A1 WO 1998018795 A1 WO1998018795 A1 WO 1998018795A1 EP 9705743 W EP9705743 W EP 9705743W WO 9818795 A1 WO9818795 A1 WO 9818795A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulas
- chlorine
- alkyl
- compound
- fluorine
- Prior art date
Links
- 0 CC(C1)*(C)=*C2=C1CC(*)=C*2* Chemical compound CC(C1)*(C)=*C2=C1CC(*)=C*2* 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Definitions
- the present invention relates first of all to an advantageous process for the preparation of the naphthyridine compounds characterized by formulas (Ia) to (Ic) below and to new intermediates which are key compounds for this process.
- Naphthyridine compounds of the formulas (Ia) to (Ic) are valuable intermediates for the preparation of active compounds, in particular highly effective bactericides (see, for example, US Pat. No. 5,164,402, US Pat. No. 5,298,629 and EP-OS 413 455).
- naphthyridine compounds of the formula (Ia) by reacting a halogenated nicotinoyl chloride with a malonic ester, then decarboxylating one of the two carboxylate groups, then converting the methylene group between the two carbonyl groups into an using an ortho-ester
- R represents hydrogen or C r C 4 alkyl
- n 1, 2 or 3, found
- R 1 represents C r C 4 alkyl
- R and R independently of one another represent C j -C 6 alkyl, where the alkyl chain can in each case optionally be interrupted by O, S or NH,
- R ', R 1 and R 2 have the meaning given for formula (III),
- Ar has the meaning given in the formulas (la) to (Ic)
- Ar, n and shark are those given in formulas (la) to (Ic),
- R and to the extent that R is C 1 -C 4 -alkyl can each be straight-chain or branched and can be, for example, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl.
- R preferably represents hydrogen, methyl or ethyl.
- R preferably represents methyl or ethyl.
- the substituents can be, for example
- Ar is preferably phenyl, 2,4-difluorophenyl, 2-fluorophenyl or 4-fluorophenyl.
- Shark is preferably fluorine or chlorine. When there are two sharks, one is preferably fluorine and the other is chlorine. When there are three sharks, 1 to 2 are preferably fluorine and the rest are chlorine. It is further preferred that a fluorine substituent is located on the carbon atom in the meta position to the carbonyl group (this is the 6 position in formula (Ia) and the corresponding position in the other formulas).
- Hai ' is preferably chlorine, n is preferably 2.
- R 1 and R 2 are preferably the same and each represent methyl or ethyl, in particular ethyl.
- the reaction of compounds of the formulas (Ha) to (IIc) with a compound of the formula (III) can be carried out, for example, by initially introducing the compound of the formula (III), a solvent and a base and a compound of the formulas (Ha ) to (IIc).
- the reactants can be used in any ratio to one another.
- the molar ratio of the compound of the formulas (Ha) to (IIc) to the compound of the formula (III) is preferably 0.8 to 1.2: 1, in particular 0.9 to 1.1: 1.
- inorganic and organic bases can be used as bases.
- bases which are sparingly soluble in the reaction mixture for example inorganic bases
- a phase transfer catalyst for example inorganic bases
- Organic bases for example amines
- Tertiary amines which contain, for example, three identical or different C 1 -C 6 -alkyl groups such as triethylamine are particularly preferred.
- the amount of base should be at least the stoichiometrically required amount, a small excess is preferred, for example up to 120% by weight of the stoichiometrically required amount.
- chlorinated hydrocarbons and aromatics are suitable as solvents.
- reaction temperature can be, for example, in the range from -10 to + 80 ° C. In general, it is advantageous to stir at the reaction temperature for a while after the reactants have been combined.
- the overall process for the preparation of naphthyridine compounds of the formulas (Ic) to Ic) can be carried out in the reactor in which the fully reacted reaction mixture of reacting a compound of the formulas (Ila) to (IIc) with a compound of the formula (III) is present. Isolation of the compound of the formulas (IVa) to (IVc) produced is not necessary for this.
- reaction of a compound of the formulas (IVa) to (IVc) with a compound of the formula (V) to a compound of the formulas (Via) to (VIc) can be carried out e.g. carry out such that a compound of the formulas (IVa) to (IVc), preferably in the form of the fully reacted reaction mixture obtained in its preparation, is acidified and at temperatures of, for example, below
- (V) preferably 0.8 to 1.2: 1, in particular 0.9 to 1.1: 1.
- inorganic and organic acids can be used for acidification.
- the amount of acid can be chosen, for example, so that there is a slight excess with respect to the base used. The amount of acid can thus be, for example, up to 125 equivalent%, based on the base used.
- the laundry can e.g. at temperatures from room temperature to 95 ° C.
- the dipolar aprotic solvent can be, for example, dimethylformamide, dimethyl sulfoxide, tetramethylene sulfone or N-methylpyrrolidone.
- Suitable acid scavengers are alkali metal salts such as alkali metal fluorides, carbonates, bicarbonates and hydrides. The following may be mentioned as individual examples: sodium fluoride, sodium hydride, sodium carbonate, sodium bicarbonate, potassium fluoride and potassium bicarbonate. It is advantageous to use the acid scavenger in an excess, for example in an excess of 10 to 50% by weight, based on the theoretical required amount. It is also advantageous to carry out the cyclization under as anhydrous conditions as possible.
- an aqueous acid can be added until a pH e.g. in the
- naphthyridine compounds of the formulas (la) to (Ic) in purities of over 99%, often over 99.8%, and in yields (based on halogenated acid chloride of the formulas (I ⁇ a) to (IIc)) of over 80% d. Th. Received.
- the process according to the invention is advantageous not only because of these good results in terms of yield and purity, but also because it is particularly simple, requires only two reaction vessels and delivers highly pure products without the isolation of intermediate stages. In view of the prior art described at the outset, this is extremely surprising.
- n 1, 2 or 3
- Ar represents optionally substituted phenyl.
- Example 2 The procedure was first as in Example 2. The washed toluene solution obtained there was metered in over 3 hours onto a template heated to 60 ° C. from 250 ml of N-methylpyrrolidone and 28 g of anhydrous potassium carbonate. At the same time, toluene was continuously distilled off in vacuo.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL97332941A PL332941A1 (en) | 1996-10-30 | 1997-10-17 | Method of obtaining naphtyridinic compounds and novel intermediate compounds |
CA002269984A CA2269984A1 (en) | 1996-10-30 | 1997-10-17 | Method or producing naphthyridine compounds and novel intermediate products |
AU50508/98A AU5050898A (en) | 1996-10-30 | 1997-10-17 | Method or producing naphthyridine compounds and novel intermediate products |
IL12959797A IL129597A0 (en) | 1996-10-30 | 1997-10-17 | Process for the preparation of naphthyridine compounds and novel intermediates |
EP97913157A EP0935600A1 (de) | 1996-10-30 | 1997-10-17 | Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte |
JP10519989A JP2001502715A (ja) | 1996-10-30 | 1997-10-17 | ナフチリジン化合物および新規中間体の製造体 |
CZ991549A CZ154999A3 (cs) | 1996-10-30 | 1997-10-17 | Způsob výroby nafthyridinových sloučenin a nové meziprodukty pro tuto výrobu |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19643826.8 | 1996-10-30 | ||
DE1996143826 DE19643826A1 (de) | 1996-10-30 | 1996-10-30 | Verfahren zur Herstellung von Naphthyridinverbindungen und neue Zwischenprodukte |
DE19648214A DE19648214A1 (de) | 1996-11-21 | 1996-11-21 | Verfahren zur Herstellung von Naphthyridinverbindungen und neue Zwischenprodukte |
DE19648214.3 | 1996-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998018795A1 true WO1998018795A1 (de) | 1998-05-07 |
Family
ID=26030644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1997/005743 WO1998018795A1 (de) | 1996-10-30 | 1997-10-17 | Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0935600A1 (de) |
JP (1) | JP2001502715A (de) |
KR (1) | KR20000052892A (de) |
CN (1) | CN1235605A (de) |
AU (1) | AU5050898A (de) |
CA (1) | CA2269984A1 (de) |
CZ (1) | CZ154999A3 (de) |
IL (1) | IL129597A0 (de) |
PL (1) | PL332941A1 (de) |
WO (1) | WO1998018795A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541480B2 (en) | 1997-08-06 | 2003-04-01 | Suntory Limited | 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132845A2 (de) * | 1983-07-27 | 1985-02-13 | Dainippon Pharmaceutical Co., Ltd. | 1,8-Naphthyridinderivate und Verfahren zu ihrer Herstellung |
FR2614620A1 (fr) * | 1984-04-26 | 1988-11-04 | Toyama Chemical Co Ltd | Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents anti-bacteriens les contenant |
DE4425647A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren |
-
1997
- 1997-10-17 KR KR1019990703756A patent/KR20000052892A/ko not_active Application Discontinuation
- 1997-10-17 CZ CZ991549A patent/CZ154999A3/cs unknown
- 1997-10-17 AU AU50508/98A patent/AU5050898A/en not_active Abandoned
- 1997-10-17 PL PL97332941A patent/PL332941A1/xx unknown
- 1997-10-17 IL IL12959797A patent/IL129597A0/xx unknown
- 1997-10-17 JP JP10519989A patent/JP2001502715A/ja active Pending
- 1997-10-17 WO PCT/EP1997/005743 patent/WO1998018795A1/de not_active Application Discontinuation
- 1997-10-17 CN CN97199280A patent/CN1235605A/zh active Pending
- 1997-10-17 EP EP97913157A patent/EP0935600A1/de not_active Withdrawn
- 1997-10-17 CA CA002269984A patent/CA2269984A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132845A2 (de) * | 1983-07-27 | 1985-02-13 | Dainippon Pharmaceutical Co., Ltd. | 1,8-Naphthyridinderivate und Verfahren zu ihrer Herstellung |
FR2614620A1 (fr) * | 1984-04-26 | 1988-11-04 | Toyama Chemical Co Ltd | Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents anti-bacteriens les contenant |
DE4425647A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541480B2 (en) | 1997-08-06 | 2003-04-01 | Suntory Limited | 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN1235605A (zh) | 1999-11-17 |
JP2001502715A (ja) | 2001-02-27 |
PL332941A1 (en) | 1999-10-25 |
CZ154999A3 (cs) | 1999-08-11 |
CA2269984A1 (en) | 1998-05-07 |
IL129597A0 (en) | 2000-02-29 |
AU5050898A (en) | 1998-05-22 |
KR20000052892A (ko) | 2000-08-25 |
EP0935600A1 (de) | 1999-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2914494C2 (de) | ||
DE69723846T2 (de) | Verfahren zur Herstellung von Sildenafil | |
CH639662A5 (de) | Imidazoazine und imidazodiazine. | |
DE2655009C2 (de) | ||
DE69837100T2 (de) | Verfahren zur synthese von chinolinderivaten | |
DE69826845T2 (de) | Verfahren zur herstellung von arylsulfonylchlorid | |
EP0017181A1 (de) | Neues Verfahren zur Herstellung von Imidazobenzodiazepinderivaten sowie Zwischenprodukte zu deren Herstellung | |
WO1998018795A1 (de) | Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte | |
EP1685098B1 (de) | Ortho-substituierte pentafluorsulfanyl-benzole, verfahren zu ihrer herstellung sowie ihre verwendung ais wertvolle synthese-zwischenstufen | |
DE2633992A1 (de) | Neue pyrazol-derivate, ihre herstellung und verwendung | |
EP0693466B1 (de) | Verfahren zur Herstellung von aromatischen fluorierten Verbindungen und neue Diamide | |
EP0453885A2 (de) | Verfahren zur Herstellung aromatischer Amine | |
EP0091044B1 (de) | Verfahren zur Herstellung von 4-Hydroxy-3-(heterocyclocarbamoyl)-2H-1,2-benzothiazin-1,1-dioxiden | |
EP0245646B1 (de) | Verfahren zur Herstellung von 1-Aryl-5-amino-pyrazolen | |
CH631170A5 (de) | Verfahren zur herstellung von 2-alkyl- oder 2-cycloalkyl-4-methyl-6-hydroxypyrimidinen. | |
DE19643826A1 (de) | Verfahren zur Herstellung von Naphthyridinverbindungen und neue Zwischenprodukte | |
DE2245363A1 (de) | Pyridopyrimidone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
CH627430A5 (en) | Process for preparing alpha -ketocarboxylic acids | |
EP0004322A1 (de) | Isochinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln | |
DE19648214A1 (de) | Verfahren zur Herstellung von Naphthyridinverbindungen und neue Zwischenprodukte | |
DE3153481C2 (de) | Zwischenstufen zur Herstellung herbizid wirksamer 2-(2-Imidazolin-2-yl)-pyridine und -chinoline | |
EP0341478A2 (de) | Verfahren zur Herstellung von 2,3-Dichlor-5-acetylpyridin | |
DE69928107T2 (de) | Heterozyklus mit thiophenol gruppe, intermediate zur herstellung und herstellungsverfahren für beide stoffgruppen | |
DE2353580C2 (de) | Verfahren zur Herstellung von o-Acylamino-diarylverbindungen | |
EP0420815B1 (de) | Verfahren zur Herstellung von 2-(2-Halogenethylthio)-phenylsulfonamiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97199280.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997913157 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1998 519989 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09297165 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2269984 Country of ref document: CA Ref document number: 2269984 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997003756 Country of ref document: KR Ref document number: PA/a/1999/004020 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1999-1549 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: PV1999-1549 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1997913157 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997913157 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997003756 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1999-1549 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997003756 Country of ref document: KR |